Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

High ERp5/ADAM10 expression in lymph node microenvironment and impaired NKG2D ligands recognition in Hodgkin lymphomas

Maria Raffaella Zocchi, Silvia Catellani, Paolo Canevali, Sara Tavella, Anna Garuti, Barbara Villaggio, Annalisa Zunino, Marco Gobbi, Giulio Fraternali-Orcioni, Annalisa Kunkl, Jean-Louis Ravetti, Silvia Boero, Alessandra Musso, Alessandro Poggi

Blood (2012) 119 (6): 1479–1489.

https://doi.org/10.1182/blood-2011-07-370841

Published: 2012

Includes: Supplemental data

Journal Articles

Imatinib Mesylate Treatment Increases Lymphoplasmocytoid Cells through SDF-1 and BMP4/7 Production in the Bone Marrow of Patients with Chronic Myelogenous Leukaemia: Relationship with Clinical/Haematological Response.

Ivana Pierri, Alessandro Poggi, Silvia Catellani, Francesca Olcese, Marco Gobbi, Maria Raffaella Zocchi

Blood (2009) 114 (22): 3263.

https://doi.org/10.1182/blood.V114.22.3263.3263

Published: 2009

Journal Articles

Vδ1 T lymphocytes producing IFN-γ and IL-17 are expanded in HIV-1–infected patients and respond to Candida albicans

Daniela Fenoglio, Alessandro Poggi, Silvia Catellani, Florinda Battaglia, Alessandra Ferrera, Maurizio Setti, Giuseppe Murdaca, Maria Raffaella Zocchi

Blood (2009) 113 (26): 6611–6618.

https://doi.org/10.1182/blood-2009-01-198028

Published: 2009

Includes: Supplemental data

Journal Articles

Evidence for Increased Bone Marrow Lymphoplasmocytoid Cells and SDF1 Secretion in imatinib Treated CML. Relationship with Clinical/hemathological Response

Ivana Pierri, Silvia Catellani, Francesca Olcese, Raffaella Grasso, Nicoletta Colombo, Marco Gobbi, Alessandro Poggi, Maria Raffaella Zocchi

Blood (2008) 112 (11): 4256.

https://doi.org/10.1182/blood.V112.11.4256.4256

Published: 2008

Journal Articles

Relationship between Clinical/Hematological Response and Increase of Plamacells in the Bone Marrow of Patients with Chronic Myelogenous Leukemia Imatinib Mesylate Treatment (631).

Alessandro Poggi, MD, Ivana Pierri, M.D., Silvia Catellani, Francesca Olcese, M.D., Antonella Marasco, Marta Zancolli, Maurizio Miglino, M.D., Nicoletta Colombo, Marco Gobbi, M.D., Maria R. Zocchi, M.D.

Blood (2007) 110 (11): 4552.

https://doi.org/10.1182/blood.V110.11.4552.4552

Published: 2007

Journal Articles

Expansion of Vδ1 T lymphocytes producing IL-4 in low-grade non-Hodgkin lymphomas expressing UL-16–binding proteins

Silvia Catellani, Alessandro Poggi, Andrea Bruzzone, Patrizia Dadati, Jean Louis Ravetti, Marco Gobbi, Maria Raffaella Zocchi

Blood (2006) 109 (5): 2078–2085.

https://doi.org/10.1182/blood-2006-06-028985

Published: 2006

NARROW

High ERp5/ADAM10 expression in lymph node microenvironment and impaired NKG2D ligands recognition in Hodgkin lymphomas

Imatinib Mesylate Treatment Increases Lymphoplasmocytoid Cells through SDF-1 and BMP4/7 Production in the Bone Marrow of Patients with Chronic Myelogenous Leukaemia: Relationship with Clinical/Haematological Response.

Vδ1 T lymphocytes producing IFN-γ and IL-17 are expanded in HIV-1–infected patients and respond to Candida albicans

Evidence for Increased Bone Marrow Lymphoplasmocytoid Cells and SDF1 Secretion in imatinib Treated CML. Relationship with Clinical/hemathological Response

Relationship between Clinical/Hematological Response and Increase of Plamacells in the Bone Marrow of Patients with Chronic Myelogenous Leukemia Imatinib Mesylate Treatment (631).

Expansion of Vδ1 T lymphocytes producing IL-4 in low-grade non-Hodgkin lymphomas expressing UL-16–binding proteins

Email alerts

ASH Publications

American Society of Hematology

High ERp5/ADAM10 expression in lymph node microenvironment and impaired NKG2D ligands recognition in Hodgkin lymphomas

Imatinib Mesylate Treatment Increases Lymphoplasmocytoid Cells through SDF-1 and BMP4/7 Production in the Bone Marrow of Patients with Chronic Myelogenous Leukaemia: Relationship with Clinical/Haematological Response.

Vδ1 T lymphocytes producing IFN-γ and IL-17 are expanded in HIV-1–infected patients and respond to Candida albicans

Evidence for Increased Bone Marrow Lymphoplasmocytoid Cells and SDF1 Secretion in imatinib Treated CML. Relationship with Clinical/hemathological Response

Relationship between Clinical/Hematological Response and Increase of Plamacells in the Bone Marrow of Patients with Chronic Myelogenous Leukemia Imatinib Mesylate Treatment (631).

Expansion of Vδ1 T lymphocytes producing IL-4 in low-grade non-Hodgkin lymphomas expressing UL-16–binding proteins

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only